Two New Treatments for Gonorrhea; one is available now!

Two New Treatments for Gonorrhea; one is available now!

In this episode of the Conversations with CEI, infectious disease specialist Dr. Steven Fine delves into groundbreaking advancements in the treatment of urogenital gonorrhea. The episode highlights the FDA's December 2025 approval of two innovative oral therapies that mark a significant step forward in combating this prevalent sexually transmitted infection.

Dr. Fine discusses the first of these treatments, Zoliflodacin (Nuzolvence), a novel medication specifically developed for urogenital gonorrhea. Administered as a single oral dose, it offers patients a convenient and effective option. The second treatment, Gepotidacin (Blujepa), is a versatile drug initially approved in March 2025 for urinary tract infections (UTIs). Now, it has been authorized for urogenital gonorrhea treatment, requiring two oral doses for optimal efficacy.

Throughout the episode, Dr. Fine provides insights into the clinical trials, mechanisms of action, and potential impact of these therapies on public health. He also emphasizes the importance of addressing antibiotic resistance in gonorrhea and how these new treatments may help mitigate this growing concern.

For more information, listeners can refer to the FDA's official announcement and other resources provided below.

Tune in to this episode to learn more about these exciting developments and their implications for the future of infectious disease treatment. Related Content:

Jaksot(59)

Reflections from the 2024 CDC STI Prevention Conference

Reflections from the 2024 CDC STI Prevention Conference

For the first time since 2018 and since the COVID-19 pandemic, the Centers for Disease Control and Prevention hosted their biennial STI Prevention Conference in-person in Atlanta, GA from September 16...

7 Marras 202422min

The Case for Chronic Pain Management among People Who Use Opioids

The Case for Chronic Pain Management among People Who Use Opioids

Are current guidelines failing chronic pain patients with a history of substance-use disorders? Find out why Dr. Wang and Dr. Kelly are calling for urgent policy changes and how updated guidelines can...

10 Loka 202446min

An Exciting New Twice-yearly Option for HIV PrEP

An Exciting New Twice-yearly Option for HIV PrEP

“This podcast discusses the recent presentation of data for lenacapavir, a potent capsid inhibitor for HIV that was 100% effective in preventing HIV infection in cis-gender woman at risk for HIV. If a...

10 Syys 202413min

When HIV Tests Perplex: Expert Insights on Ambiguous and Discordant Results

When HIV Tests Perplex: Expert Insights on Ambiguous and Discordant Results

Providers calling into our CEI hotline often ask me what to do when their patient's HIV test results are unclear. These ambiguous or discordant test results can be a source of anxiety and confusion fo...

8 Elo 202429min

It’s Complicated…but Necessary! Navigating Confidential Sexual Healthcare for Adolescents

It’s Complicated…but Necessary! Navigating Confidential Sexual Healthcare for Adolescents

“Nobody goes into adolescent medicine or into a field of medicine that serves adolescent patients because it’s simple and straightforward, right?” In May 2024, the New York State Department of Health ...

11 Heinä 202422min

Special Conversations with CEI: Best Practices for Hepatitis C and Pregnancy Screening: Advice from a Fellow Clinician

Special Conversations with CEI: Best Practices for Hepatitis C and Pregnancy Screening: Advice from a Fellow Clinician

Hepatitis C virus (HCV) is a pathogen spread by contact with blood from a person with HCV infection. Prevalence among the US obstetric population rose nearly 10-fold over the past 20 years and approxi...

13 Kesä 202434min

Special Conversations with CEI: Best Practices for Working with People Who Use Substances

Special Conversations with CEI: Best Practices for Working with People Who Use Substances

Hepatitis C virus (HCV) is a pathogen spread by contact with blood from a person with HCV infection. Prevalence among the US obstetric population rose nearly 10-fold over the past 20 years and approxi...

6 Kesä 202430min

Special Conversations with CEI: The Impact of Hepatitis C Screening during Pregnancy: A Client’s Story

Special Conversations with CEI: The Impact of Hepatitis C Screening during Pregnancy: A Client’s Story

Hepatitis C virus (HCV) is a pathogen spread by contact with blood from a person with HCV infection. Prevalence among the US obstetric population rose nearly 10-fold over the past 20 years and approxi...

30 Touko 202436min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-narsisti
adhd-podi
rss-liian-kuuma-peruna
rss-niinku-asia-on
aamukahvilla
rss-valo-minussa-2
rss-koira-haudattuna
kesken
psykologia
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-vapaudu-voimaasi
rss-arkea-ja-aurinkoa-podcast-espanjasta
leveli
rss-luonnollinen-synnytys-podcast
aloita-meditaatio
jari-sarasvuo-podcast
rss-taloustaito-podcast